Which has the lower trailing P/E, KRYS or MOH?

KRYS has the lower trailing P/E: KRYS trades at 40.59 and MOH at 1010.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is KRYS or MOH more profitable?

KRYS runs the higher net margin — KRYS at 54.82% versus MOH at -0.02%.

How have KRYS and MOH total returns compared?

Over the past 5 years, KRYS delivered 44.28% and MOH delivered -6.35% annualized total return. Past performance doesn't predict future results.

Krystal Biotech, Inc. (KRYS) vs Molina Healthcare, Inc. (MOH)

A side-by-side comparison of Krystal Biotech, Inc. and Molina Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KRYS

Krystal Biotech, Inc.

$9.55B

$323.93HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT

MOH

Molina Healthcare, Inc.

$10.02B

$192.00HealthcareDelayed quote: Oct 6, 2026, 1:19 PM EDT

Total return — KRYS vs MOH

growth of $100 · dividends reinvested · last 9y

KRYS +3047.1% (+46.7%/yr)MOH +193.4% (+12.7%/yr)KRYS compounded faster over this window

Log scale — wide-divergence pair

KRYS MOH

KRYS vs MOH: by the numbers

•MOH is the larger company ($10.02B vs $9.55B market cap).
•KRYS trades at the lower trailing earnings multiple (40.59 vs 1010.53 P/E), one valuation lens rather than an overall verdict.
•KRYS is profitable (54.82% net margin) while MOH runs a net loss (-0.02%).

Metrics side by side

Valuation

Metric	KRYS	MOH
P/E ratio	40.59	1010.53
Forward P/E	42.58	N/A
P/S ratio	21.68	0.23
P/B ratio	7.03	2.40
EV / EBITDA	44.68	19.38
FCF yield	2.70%	2.68%

Profitability

Metric	KRYS	MOH
Gross margin	93.34%	13.07%
Operating margin	44.93%	0.66%
Net margin	54.82%	-0.02%
ROE	17.77%	-0.17%
ROIC	14.41%	3.56%

Growth (annualized)

Metric	KRYS	MOH
Revenue CAGR (5Y)	N/A	13.56%
EPS CAGR (5Y)	N/A	-4.78%
FCF CAGR (5Y)	N/A	-33.98%
Total return CAGR (5Y)	44.28%	-6.35%

Frequently asked

Which has the lower trailing P/E, KRYS or MOH?: KRYS has the lower trailing P/E: KRYS trades at 40.59 and MOH at 1010.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is KRYS or MOH more profitable?: KRYS runs the higher net margin — KRYS at 54.82% versus MOH at -0.02%.
How have KRYS and MOH total returns compared?: Over the past 5 years, KRYS delivered 44.28% and MOH delivered -6.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KRYS analysis Full MOH analysis Interactive comparison tool

Dig into the metrics

Krystal Biotech P/E ratio Molina Healthcare P/E ratio Krystal Biotech ROE Molina Healthcare ROE Krystal Biotech operating margin Molina Healthcare operating margin Krystal Biotech revenue growth Molina Healthcare revenue growth Krystal Biotech free cash flow Molina Healthcare free cash flow

Krystal Biotech & Molina Healthcare appear in these rankings

Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.